The latest Investing Matters Podcast episode with Inclusive Asset Management's Alexandra McGuigan has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,610.50
Bid: 1,607.50
Ask: 1,608.00
Change: -33.00 (-2.01%)
Spread: 0.50 (0.031%)
Open: 1,626.50
High: 1,626.50
Low: 1,594.50
Prev. Close: 1,643.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. Stocks on the Move-Energy stocks, Lands' End, Synthesis

Wed, 10th Dec 2014 18:03

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)

U.S. stocks were lower near midday on Wednesday, weighed down bya sharp decline in the energy sector on the latest weakness inoil prices. The Dow Jones industrial average was down0.86 percent at 17,647.51, the S&P 500 was down 0.76percent at 2,044.21 and the Nasdaq Composite was down0.65 percent at 4,735.57.

** GLAXOSMITHKLINE PLC, $43.22, -2.02 pct

Bank of America Merrill Lynch cut its rating to"underperform" from "neutral" on Britain's biggest drugmaker, citing near-term margin pressures, lower long-termexpectations for new respiratory products and reduced buybacksgiven lower earnings.

** SEVENTY SEVEN ENERGY INC, $4.81, -14.87 pct

** REX ENERGY CORP, $5.17, -5.40 pct

** SANCHEZ ENERGY CORP, $7, -7.53 pct

** HALCON RESOURCES CORP, $1.735, -8.68 pct

** WHITING PETROLEUM CORP, $31.25, -6.86 pct

** BREITBURN ENERGY PARTNERS LP, $9.36, -8.50 pct

** CALIFORNIA RESOURCES CORP, $5.68, -7.19 pct

Oil and gas companies' stocks fell as global oil pricestouched a five-year low and at least 4 brokerages cut ratingsand price targets on about 50 companies. Brent crude oil fell more than $2 a barrel to a new five-year low on forecaststhat oversupply would keep building until next year after OPECdecided not to cut output.

** CONOCOPHILLIPS, $63.37, -2.45 pct

** CHEVRON CORP, $103.708, -3.09 pct

** ENERGY XXI (BERMUDA) LTD, $2.95, -7.81 pct

** GOODRICH PETROLEUM CORP, $3.53, -13.69 pct

** OASIS PETROLEUM INC, $11.6, -8.37 pct

** CONTINENTAL RESOURCES INC, $33.82, -6.52 pct

** HESS CORP, $68.85, -4.61 pct

U.S. oil and gas producers are scaling back capital spendingplans for 2015, following a sharp decline in oil prices over thepast six months. Global oil and gas exploration projects worthmore than $150 billion are likely to be put on hold in 2015 asplunging oil prices render them uneconomic, according to datafrom Norwegian consultancy Rystad Energy.

** YUM! BRANDS INC, $71.58, -4.84 pct

At least three brokerages, including Barclays Capital, cutprice targets on the stock after the company on Tuesday loweredits full-year profit forecast for the second time, hurt by aslower-than-expected recovery in China after a food safety scarein July.

"The question remains whether the China segment will everreturn to full strength," Barclays analyst Jeffrey Bernsteinwrote in a note, cutting his price target to $74 from $75.

** AMERICAN AIRLINES GROUP INC, $49.8784, +3.25 pct

** UNITED CONTINENTAL HOLDINGS INC, $65.5, +4.77 pct

** DELTA AIR LINES INC, $46.95, +1.34 pct

** SOUTHWEST AIRLINES CO, $42.5, +4.35 pct

** JETBLUE AIRWAYS, $15.46, +2.76 pct

** UNITED CONTINENTAL, $65.5, +4.77 pct

U.S. airline operators' shares rose after Barclays saidlower oil prices may help companies next year. Airlines stand tosee a decline of about $10 billion in fuel costs in 2015,analyst David Fintzen wrote in a note.

** LANDS' END INC, $46.75, -7.72 pct

The apparel retailer's third-quarter revenue fell 3 percentdue to lower international sales and weaker sales at its shopswithin Sears Holdings Corp outlets. Lands' End was spunoff from Sears last year.

** SYNTHESIS ENERGY SYSTEMS INC, $0.9975, +16.00pct

The clean energy company's China joint venture partner,Zhangjiagang Chemical Machinery Co Ltd, securedorders worth more than $105 million for three industrial syngassupply plants.

** ALLOT COMMUNICATIONS LTD, $8.2, -9.29 pct

BofA Merrill Lynch downgraded the Israel-based bandwidthmanagement services company's U.S.-listed shares to"underperform" from "buy" and cut its target price to $10.5 from$17.

"We have concerns over Allot's key fundamentals, weakcarrier spending, uncertainty surrounding Title 2 reform (thatenables FCC to enforce net neutrality) in the US and recentmanagement departures," BofA analysts wrote in a note.

** COMSTOCK RESOURCES INC, $5.76, -11.52 pct

FBR & Co cut its price target to $8.50 from $20 on the oiland gas producer's shares, citing low commodity prices andexpectations of continued volatility.

** FRANCESCA'S HOLDINGS CORP, $15.485, +2.35 pct

The women's apparel and accessories retailer's third-quarternet sales rose 9 percent to $87.1 million, driven by a 53percent rise in e-commerce sales. Suntrust Robinson Humphreyanalyst Pamela Quintiliano said the company's fourth-quarterprofit forecast of 13-19 cents per share reflects a realisticbar for new Chief Executiver Michael Barnes.

** LAYNE CHRISTENSEN CO, $8.13, +13.07 pct

The water management company's third-quarter net loss fromcontinuing operations narrowed to 19 cents per share from 79,while analysts on average expected a loss of 50 cents per share.The company also appointed Michael Caliel from Invensys Ltd as Chief Executive after Rene Robichaud quit in June.

** VAALCO ENERGY INC, $4.66, -18.25 pct

The oil and gas company shut its Etame 8-H well offshoreGabon due to the production of hydrogen sulfide during initialtests. The company said investigations are underway to determinethe cause of sulfide production.

** CHC GROUP LTD, $3.88, -11.42 pct

The commercial helicopter operator reported second-quarterrevenue below the average analyst estimate as some customers inthe oil and gas industry delayed or canceled projects.

** YAMANA GOLD INC, $4.385, +1.98 pct

The Canadian gold miner said it will place some ofits Brazilian assets that have been deemed non-core into asubsidiary dubbed Brio Gold and will explore a potential salealong with other options for the unit in 2015.

The company said the assets being parceled off into BrioGold include Fazenda Brasileiro, C1 Santa Luz and Pilar, and itsAgua Rica project.

** PETROQUEST ENERGY INC, $3.74, -6.27 pct

FBR Capital Markets cut its price target to $6 from $8 onthe oil and gas producer's stock, citing weak oil and gasprices, slower production growth and lower capex levels.

** HOVNANIAN ENTERPRISES INC, $4.23, +8.46 pct

The U.S. homebuilder's fourth-quarter revenue jumped 18percent and orders rose 8 percent as the U.S. housing marketrecovery picks up.

** TUNIU CORP, $11.96, +5.84 pct

** CTRIP.COM, $43.461, -1.11 pct

The companies announced an agreement to expand collaborationon shared travel resources. Ctrip bought $15 million of TuniuClass A shares in May; it currently owns over 3 percent ofTuniu's outstanding shares.

** BEMIS CO INC, $42.87, +4.15 pct

BMO Capital Markets raised its rating on Tuesday to"outperform" from "market perform" and price target to $47 from$39 on the packaging material maker's stock.

An expected fall in the price of resin, which accounts for alarge part of costs, to boost company's margin, analysts wrotein note.

** SILICON GRAPHICS INTERNATIONAL CORP, $10.09,+5.43 pct

Needham & Company LLC upgraded the supercomputing servermaker's stock to "buy" from "hold".

"We are encouraged that Congress seems to be activelyworking together regarding the upcoming Federal Budget deadlineof Dec. 11, and this should provide relief to companies like SGI(Silicon Graphics) that are closely tied to Federal spendingcycles" - Needham analysts.

** CIVEO CORP, $7.64, -15.02 pct

The workforce accommodation provider's stock is to bereplaced by KLX Inc in the S&P MidCap 400 index aftermarket close on Dec. 16. Civeo gave a weak forecast lateSeptember and dropped plans of converting to a REIT.

** SEVCON INC, $8.7792, +12.41 pct

The controls maker for electric and hybrid vehicles won acontract to supply motor controllers to a "Tier-1 automotivesupplier" in Southeast Asia. The company said the contract couldresult in $50 million in revenue through 2020.

** CYREN LTD, $2.28, +30.73 pct

The Israeli cloud-based cyber security provider said some of its technology will be used in China-based mobileapplication security provider Bangcle's products. Bangcle'ssecurity software covers 500 million mobile phones worldwide.

** WARREN RESOURCES INC, $1.42, -11.80 pct

The oil and gas producer said it was deferring crude oildevelopment in Wilmington oil field due to weak prices. Warrensaid it expects capital spending to drop to about $80 million in2015.

** ENERGOUS CORP, $7.45, -6.88 pct

The company, which is developing technology to chargeelectronic devices wirelessly, priced a public offering of 2.9million shares at $7 per share, a discount of 12.5 percent tothe stock's Tuesday closing.

** BELDEN INC, $80.43, +7.35 pct

The networking and cable product maker said on Tuesday thatit would buy Portland-based cyber security firm Tripwire for$710 million. The deal is expected to add 65 cents per share toBelden's adjusted income from continuing operations in 2015.

** ARCA BIOPHARMA INC, $0.9688, +20.95 pct

ARCA said the U.S. Food and Drug Administration granted itsexperimental drug orphan drug status as a potential treatmentfor viral hemorrhagic fever after exposure to the Ebola virus.

** JPMORGAN CHASE & CO, $61.32, -1.81 pct

Fed Vice Chairman Stanley Fischer says the bank will needmore than $20 billion of additional capital to comply with theproposed extra capital cushion for the largest U.S. banks.

"While we're still reviewing the Fed's proposal, we are wellcapitalized and intend to meet their requirements and timeframes...," JPMorgan spokesman Andrew Gray said.

** CYTORI THERAPEUTICS INC, $0.5225, +12.39 pct

The U.S. FDA granted conditional approval for a key clinicaltrial to evaluate the company's cell therapy as a potentialtreatment for impaired hand function in scleroderma patients.Cytori's technology, called the Celution System, needs asuccessful pivotal trial and FDA approval before it can bemarketed in the United States.

** LINN ENERGY LLC, $13.3101, -8.96 pct

Stifel analysts cut their price target on the oil and gascompany's stock to $22 from $27, citing a lower commodity priceenvironment. The median price target on stock is $25, accordingto Thomson Reuters data.

** SEADRILL LTD, $11.53, -5.26 pct

UBS cut its price target on the Norway-based offshoredriller's Oslo-listed shares to NOK 85 from NOK 210,citing lower oil prices. Analysts expect Brent to average below$70/bbl in 2015 and also cited current market condition having anegative affect on demand for deepwater units.

** KRISPY KREME DOUGHNUTS INC, $18.48, -8.42 pct

The doughnut retailer on Tuesday reported third-quarterprofit and sales below expectations, hurt by higher promotionsto boost traffic and lower sales at company-owned stores,compared with a year earlier.

** GOLDMAN SACHS, $193.84, -1.55 pct

The U.S. Federal Reserve on Tuesday proposed requiring eightof the largest U.S. banks to hold an extra capital cushion, andsaid the firms will need more equity if they rely on risky typesof debt. Most of the banks, which include Citigroup and GoldmanSachs, would be held to higher capital requirements than under asimilar rule by global regulators, officials said.

** COMTECH TELECOMMUNICATIONS CORP, $36.7, -5.78pct

The communications equipment maker decided to remainindependent after completing review of strategic alternatives.Comtech had begun its review in August, saying that merger orsale of the company was possible.

** CITIGROUP INC, $55.3, -0.98 pct

Citigroup will record $2.7 billion in litigation expensesand another $800 million in repositioning charges, leaving thethird-largest U.S. bank "marginally profitable" in the fourthquarter, its chief executive officer said on Tuesday.

** FREEPORT-MCMORAN COPPER & GOLD INC, $24.89, -0.96pct

The U.S. miner has agreed to pay 16.3 percent more in annualprocessing charges to large Chinese copper smelters in 2015,with the 10-year high fee likely to set the benchmark for China. (Compiled by Lehar Maan in Bengaluru,; Editing by SimonJennings)

More News
Today 09:17

GSK meningococcal vaccine accepted by US FDA for review

(Sharecast News) - GSK announced on Tuesday that its five-in-one meningococcal ABCWY (MenABCWY) vaccine candidate had been accepted for regulatory review by the US Food and Drug Administration (FDA).

Read more
Today 08:59

GSK's latest meningitis vaccine accepted for review by US regulator

(Alliance News) - GSK PLC on Tuesday said it has made progress in the development of its newest candidate, which combines the strengths of two other vaccines in its portfolio into one bacteria-fighting inoculation.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
9 Apr 2024 11:45

Pfizer RSV shot meets goals in trial of high-risk adults under age 60

April 9 (Reuters) - Pfizer said on Tuesday its respiratory syncytial virus (RSV) vaccine Abrysvo was well tolerated and generated an immune response in higher risk adults under the age of 60 similar to that in older adults, for whom the shot is already approved.

Read more
8 Apr 2024 09:13

LONDON BROKER RATINGS: Wizz Air raised; HSBC cuts Rentokil to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
4 Apr 2024 13:08

UK dividends calendar - next 7 days

Friday 5 April 
BBGI Global Infrastructure SAdividend payment date
Molten Ventures PLCdividend payment date
Pennon Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
Regional REIT Ltddividend payment date
Rights & Issues Investment Trust PLCdividend payment date
Sylvania Platinum Ltddividend payment date
Titon Holdings PLCdividend payment date
Triple Point Energy Transition PLCdividend payment date
Monday 8 April 
Alumasc Group PLCdividend payment date
LondonMetric Property PLCdividend payment date
Redrow PLCdividend payment date
Tuesday 9 April 
CT Global Managed Portfolio Trust PLCdividend payment date
Downing Strategic Micro-Cap Investment Trust PLCdividend payment date
Dunelm Group PLCspecial dividend payment date
Hays PLCdividend payment date
Renishaw PLCdividend payment date
Safestore Holdings PLCdividend payment date
Wednesday 10 April 
Assura PLCdividend payment date
Primorus Investments PLCspecial dividend payment date
Wilmington PLCdividend payment date
Thursday 11 April 
Amedeo Air Four Plus Ltdex-dividend payment date
Athelney Trust PLCdividend payment date
Aviva PLCex-dividend payment date
Balanced Commercial Property Trust Ltdex-dividend payment date
Barratt Developments PLCex-dividend payment date
Begbies Traynor Group PLCex-dividend payment date
Bioventix PLCex-dividend payment date
Blackfinch Spring VCT PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
Caledonia Mining Corpex-dividend payment date
Capital & Regional PLCex-dividend payment date
Chesnara PLCex-dividend payment date
Colefax Group PLCdividend payment date
CT Private Equity Trust PLCex-dividend payment date
Downing Strategic Micro-Cap Investements Trust PLCex-dividend payment date
Driver Group PLCdividend payment date
F&C Investment Trust PLCex-dividend payment date
Foxtons Group PLCex-dividend payment date
Grafton Group PLCex-dividend payment date
GSK PLCdividend payment date
Harbour Energy PLCex-dividend payment date
Hargreaves Services PLCdividend payment date
Howden Joinery Group PLCex-dividend payment date
Hunting PLCex-dividend payment date
i3 Energy PLCex-dividend payment date
International Personal Finance PLCex-dividend payment date
International Public Partnerships Ltdex-dividend payment date
ITV PLCex-dividend payment date
Johnson Service Group PLCex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
JPMorgan Japan Small Cap Growth & Income PLCex-dividend payment date
Just Group PLCex-dividend payment date
Kenmare Resources PLCex-dividend payment date
Kerry Group PLCex-dividend payment date
Kings Arms Yard VCT PLCex-dividend payment date
Law Debenture Corp PLCdividend payment date
Lloyds Banking Group PLCex-dividend payment date
Lowland Investment Cos PLCex-dividend payment date
Luceco PLCex-dividend payment date
Man Group PLCex-dividend payment date
Manchester & London Investement Trust PLCex-dividend payment date
Marble Point Loan Financing Ltdex-dividend payment date
Mercantile Investment Trust PLCex-dividend payment date
Mobius Investment Trust PLCex-dividend payment date
MTI Wireless Edge Ltddividend payment date
North American Income Trust PLCex-dividend payment date
Northamber PLCex-dividend payment date
Octopus Apollo VCT PLCex-dividend payment date
Phoenix Group Holdings PLCex-dividend payment date
Reckitt Benckiser Group PLCex-dividend payment date
Ricardo PLCdividend payment date
Savills PLCex-dividend payment date
Schroder Asian Total Return Investment Cos PLCex-dividend payment date
Schroder European Real Estate Investment Trust PLCex-dividend payment date
Scottish American Investment Cos PLCdividend payment date
Smurfit Kappa Group PLCex-dividend payment date
Softcat PLCex-dividend payment date
Somero Enterprises Incex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
Synectics PLCex-dividend payment date
TP ICAP Group PLCex-dividend payment date
Trifast PLCdividend payment date
TT Electronics PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
4 Apr 2024 00:03

Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

NEW YORK, April 3 (Reuters) - Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.